Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-05-07

Clinical Trial Update: Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing Mannitol 20% to Hypertonic Saline 7.5% in brain metabolism and oxygenation for brain edema/metabolic disturbances has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hypertonic saline 7.5% (hypertonic saline)
  • Mannitol 20% (mannitol)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Brain Edema, Metabolic Disturbance | Phase 4 | Status: COMPLETED